Orient-3: A Randomized, Open-Label, Phase 3 Study Of Sintilimab Versus Docetaxel In Previously Treated Advanced/Metastatic Squamous Non-Small-Cell Lung Cancer (Sqnsclc).Yuankai Shi,Lin Wu,Xinmin Yu,Yan Wang,Puyuan Xing,Jianying Zhou,Airong Wang,Jianhua Shi,Yi Hu,Ziping Wang,Guangyu An,Yong Fang,Sanyuan Sun,Caicun Zhou,Changli Wang,Feng Ye,Xingya Li,Junye Wang,Mengzhao Wang,Yunpeng Liu,Yanqiu Zhao,Jifeng FengCANCER RESEARCH（2021）引用 1|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
